The slide deck “A Federated In-Memory Database Computing Platform Enabling Real-time Analysis of Big Medical Data” presented on May 17, 2017 at Intel Tech Talks hosted by SAPPHIRE 2017 in Orlando, FL is online available now.
We are happy to contribute to the “Plattform Life Sciences” issue March 2017 focusing on the digital transformation within the life sciences. In our contribution, we share latest details about our data donation pass for citizens. With its help, citizens get full access to their personal healthcare data so they can request and aggregate them from individual participants in the healthcare system and donate them for individual purposes. Thus, citizens are able to perform their right on information self-determination for the first time in an extensive way.
The slide deck of the presentation “When time matters” of the workshop “The Genomics Revolution: from navigating NGS technologies to real time analysis & integration of big bio data” on Jan 31, 2017 in London is online available now.
Further details about the Symposium on Big Data in Medicine can be found here.
We are happy to contribute to the “Management & Krankenhaus” issue Sep 2016. In our contribution, we introduce a data donation pass for patients. With the personal data donation pass, patients get fill access to their personal medical data so they can request and aggregate their data from individual participants in the healthcare system. Furthermore, patients get full control to manage access to their data, e.g. to share a de-identified subset of their data for a specific research project.
We are proud that our Analyze Genomes platform was selected as a distinguished big data project in Germany. Read more about it in the publication “Germany — Excellence in Big Data” published by the Federal Association for Information Technology, Telecommunications and New Media (BITKOM).
The slide deck “Analyze Genomes Service for Precision Medicine” presented at the mHealth meets Diagnostics Symposium on June 21, 2016 in Berlin, Germany is online available now.